-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Star Enterprise of Chemical Machinery and Equipment Network ] Capacity refers to the number of products that can be produced or the number of raw materials that can be processed under the established organizational and technical conditions for all the fixed assets that the company participates in the production during the planning period
.
In the field of pharmaceutical equipment, due to the current delivery date of imported equipment that cannot meet the needs of pharmaceutical companies, this has brought opportunities to the domestic pharmaceutical equipment industry.
Since 2020, domestic companies represented by pharmaceutical equipment giants have achieved significant increase in orders , And in the case of strong demand, pharmaceutical machinery companies need to consider how to increase production capacity to meet the growth of demand
.
Chemical machinery and equipment network star enterprise chemical machinery and equipment.
In the field of pharmaceutical equipment, due to the current delivery date of imported equipment that cannot meet the needs of pharmaceutical companies, this has brought opportunities to the domestic pharmaceutical equipment industry.
Since 2020, domestic companies represented by pharmaceutical equipment giants have achieved significant increase in orders , And in the case of strong demand, pharmaceutical machinery companies need to consider how to increase production capacity to meet the growth of demand
.
Entering 2021, whether a company's production capacity can adapt to market demand can be said to be a matter of great concern to every pharmaceutical company and many investors
.
.
For example, Chutian Technology accepted a survey of two institutions on June 16, 2021.
In the interactive session, the question of "whether the company's current production capacity can meet the demand for rapid growth in orders" has attracted the attention of institutions.
The reply stated: The company produces customized products, and its production capacity is flexible
.
In case of insufficient production capacity, it can be adjusted according to the actual situation of the order in the short term
.
Since its establishment, the company has been facing the problem of insufficient production capacity.
The vigorous investment in research and development, manufacturing capacity, and production plants is to prepare for the expansion of production capacity in advance
.
In the interactive session, the question of "whether the company's current production capacity can meet the demand for rapid growth in orders" has attracted the attention of institutions.
The reply stated: The company produces customized products, and its production capacity is flexible
.
In case of insufficient production capacity, it can be adjusted according to the actual situation of the order in the short term
.
Since its establishment, the company has been facing the problem of insufficient production capacity.
The vigorous investment in research and development, manufacturing capacity, and production plants is to prepare for the expansion of production capacity in advance
.
It is reported that Chutian Technology’s tens of billions of production capacity and the fourth phase of the project started construction on April 28, 2020.
The planned land area is 142 acres.
Chutian Technology Innovation Center Building, Talent Center Building, Central Workshop, Intelligent Chinese Medicine Workshop, Intelligent R&D, manufacturing and management units and living supporting facilities such as back package workshop, Chutianyuan creative workshop, apartment building E building
.
The total investment of the project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in the first half of 2022
.
Among them, the intelligent post-package workshop was completed on December 27, 2020, which will greatly increase the production capacity of Chutian Technology's corresponding product lines
.
In addition, Chutian Technology's fourth-phase project central workshop, intelligent Chinese medicine workshop and other projects are currently stepping up construction
.
After all is completed, it will become a medical equipment research and development and manufacturing base that affects the world
.
The planned land area is 142 acres.
Chutian Technology Innovation Center Building, Talent Center Building, Central Workshop, Intelligent Chinese Medicine Workshop, Intelligent R&D, manufacturing and management units and living supporting facilities such as back package workshop, Chutianyuan creative workshop, apartment building E building
.
The total investment of the project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in the first half of 2022
.
Among them, the intelligent post-package workshop was completed on December 27, 2020, which will greatly increase the production capacity of Chutian Technology's corresponding product lines
.
In addition, Chutian Technology's fourth-phase project central workshop, intelligent Chinese medicine workshop and other projects are currently stepping up construction
.
After all is completed, it will become a medical equipment research and development and manufacturing base that affects the world
.
Tofflon also stated in the survey on May 24 that the company has sufficient production capacity
.
The company has deployed the company’s production capacity in 2020.
It will carry out smart equipment manufacturing science and technology industrial park projects in Dongtai Xinte Industrial Park, Jiangsu Province, and invest in the construction of biopharmaceutical system equipment industrialization projects in Shanghai Jinshan Industrial Zone.
Two projects are expected The total investment is about 850 million yuan
.
The industrialization project invested by the company in the Jinshan Industrial Zone is already in the process of listing signs this year, and strives to start construction this year and put it into production next year
.
.
The company has deployed the company’s production capacity in 2020.
It will carry out smart equipment manufacturing science and technology industrial park projects in Dongtai Xinte Industrial Park, Jiangsu Province, and invest in the construction of biopharmaceutical system equipment industrialization projects in Shanghai Jinshan Industrial Zone.
Two projects are expected The total investment is about 850 million yuan
.
The industrialization project invested by the company in the Jinshan Industrial Zone is already in the process of listing signs this year, and strives to start construction this year and put it into production next year
.
It can be seen that, in response to the capacity challenge, most of the large pharmaceutical companies have adopted measures such as building new plants, and the time required is basically more than one year
.
If these measures are successfully implemented, they can effectively change the status quo of insufficient production capacity of enterprises and greatly increase production capacity, but they also require a large amount of capital investment
.
.
If these measures are successfully implemented, they can effectively change the status quo of insufficient production capacity of enterprises and greatly increase production capacity, but they also require a large amount of capital investment
.
It is worth mentioning that most of China's pharmaceutical machinery companies are mainly small and medium-sized enterprises, and there are certain challenges in terms of capital and technology
.
So, under the background that the domestic pharmaceutical machinery industry is fading away from the cycle and ushering in growth, how can small and medium pharmaceutical machinery companies seize the opportunity to increase production capacity?
.
So, under the background that the domestic pharmaceutical machinery industry is fading away from the cycle and ushering in growth, how can small and medium pharmaceutical machinery companies seize the opportunity to increase production capacity?
The industry believes that small and medium-sized pharmaceutical machinery companies can consider short- and medium-term factors.
For example, they can adopt new process equipment, or carry out small-scale transformation and innovation of equipment, or they can increase their equipment in the short- and medium-term by temporarily increasing workers, working overtime, etc.
The production capacity meets part of the market demand
.
For example, in the context of modern pharmaceutical companies generally facing challenges such as rising costs and capacity expansion, pharmaceutical companies can continue to innovate and improve equipment technology and processes, create more automated and intelligent pharmaceutical equipment , and help pharmaceutical companies improve production automation Level, improve production efficiency and reduce costs
.
Pharmaceutical equipment For example, they can adopt new process equipment, or carry out small-scale transformation and innovation of equipment, or they can increase their equipment in the short- and medium-term by temporarily increasing workers, working overtime, etc.
The production capacity meets part of the market demand
.
For example, in the context of modern pharmaceutical companies generally facing challenges such as rising costs and capacity expansion, pharmaceutical companies can continue to innovate and improve equipment technology and processes, create more automated and intelligent pharmaceutical equipment , and help pharmaceutical companies improve production automation Level, improve production efficiency and reduce costs
.
It is reported that a small-scale pump and valve company continues to work in the field of commercial pharmaceutical fluid transportation.
Through technological accumulation, the newly developed pump and valve products not only achieve double guarantees in technology and quality, but also can be well adapted to the pharmaceutical industry.
The demand for upgrading and upgrading of the industry; there are also solid material weighing and packaging equipment manufacturers in the Chinese medicine industry segmented market that will actively embrace digitalization and continue to work to improve the digital and intelligent level of equipment, so as to bring efficiency, speed and efficiency to industrial production.
Benefits of the application of personnel
.
Through technological accumulation, the newly developed pump and valve products not only achieve double guarantees in technology and quality, but also can be well adapted to the pharmaceutical industry.
The demand for upgrading and upgrading of the industry; there are also solid material weighing and packaging equipment manufacturers in the Chinese medicine industry segmented market that will actively embrace digitalization and continue to work to improve the digital and intelligent level of equipment, so as to bring efficiency, speed and efficiency to industrial production.
Benefits of the application of personnel
.
Original title: With strong market demand, how should pharmaceutical machinery companies increase their production capacity?
